☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Medexus
Medexus Signs a Multiple Agreement with NXDC to Commercialize Gleolan for the Treatment of Glioma in the US
March 2, 2022
PharmaShots Weekly Snapshot (March 02-06, 2020)
March 9, 2020
Load more...
Back to Home
